* Mr. THOMPSON of Mississippi. Mr. Speaker, I and others have spoken at length on the ways that this bill will improve health care for all of our constituents. Another significant benefit of this legislation which has not received as much attention will be the creation of new high-paying jobs in this country. Let me repeat that for some of my friends on the other side of the aisle, this bill will create high-paying, high-quality jobs in health care delivery, technology, and research in the United States.
* First, this bill will create enormous demand for health care workers, especially in the area of primary care. Insuring millions of Americans in this country who currently have no insurance will allow them to see primary care providers and receive the wellness and preventive care they have been denied for too long. This influx of new patients will need doctors, nurses and technicians for their care, while reducing overall health care costs because they will not need much more expensive hospitalizations. I support channeling resources that for too long have been used to treat people once they become sick into jobs and services that will prevent people from getting sick in the first place.
* Second, this bill will continue the efforts we began in the stimulus package to deploy new health information technologies that better manage both the quality of care patients receive and the cost at which they receive it. New health care exchanges and new demands on the health system to provide high-quality and cost-effective health care will create new opportunities and markets for our brightest minds in technology. They will be incentivized to create and develop products that will be a win/win for Americans: high-quality health care at an affordable price.
* Third, this bill will create high-quality research opportunities in this country. The Energy and Commerce Committee enacted a framework for allowing biosimilar competition in this country. This new class of medicines will help lower costs and bring competition to one area that is key to the future of our health care system. Biotechnology is on the cutting edge of efforts to reduce costly invasive procedures and allow our constituents to live healthier and more productive lives. The creation of this new class of medicines comes with requirements for new clinical research and testing, especially in the area of whether a new biosimilar can be interchangeable with an innovator's product. This research will create high-quality and high-paying jobs and it is imperative that we keep this research and these jobs in this country. We cannot allow these research opportunities to leave the United States and we must ensure that these new medicines are safe. I intend to work with the Secretary of HHS and the Commissioner of the FDA to ensure that the testing and research on these biosimilars occur in this country to make certain that it is done properly and safely and to benefit our economy.
* Mr. Speaker, this bill is an investment and an exciting opportunity to create the kind of jobs we so desperately need in this United States while at the same time improving the lives of all Americans. This bill will improve health care, create jobs, and grow our economy.